Managing psychosis in the office setting – British Columbia Centre for Excellence

Skip to content

ABOUT
TREATMENT AS
PREVENTION®
HOPE TO HEALTH
RESEARCH & INNOVATION
CENTRE
DRUG TREATMENT
PROGRAMS
RESEARCH

ABOUT
TREATMENT AS
PREVENTION®
HOPE TO HEALTH
RESEARCH & INNOVATION
CENTRE
DRUG TREATMENT
PROGRAMS
RESEARCH

Managing psychosis in the office setting

May 17, 2020
CPD Learning Series for Hope to Health Staff

Dr. Tanya Fairweather, MD, CCFP, FCFP
Clinical Assistant Professor, UBC Faculty of Medicine
VGH Tertiary Mental Health GP
DTES Research and Innovation Centre, Hope to Health Clinic, BC-CfE

Share this video:

PrevPreviousCOVID-19, the BC-CfE Update

NextAn Update on the BC-CfE HIV Prevention and Treatment Guidelines and Training ProgramNext

Privacy Notice|Privacy Statement|Personal Information Banks|Website Privacy Policy

© 2025 British Columbia Centre for Excellence
St. Paul's Hospital 608–1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
Tel: 604-806-8477 | Fax: 604-806-9044
General inquiries: info@bccfe.ca
Media inquiries: communications@bccfe.ca

(Please do not use any of these email addresses to send personal information or book an appointment.
To book appointments or contact the H2H clinic, please call 604-416-1517 or fax: 604-564-4893.
Do not send your or your client's personal information via email.)

Scroll to Top

CLICK FOR GP-41 DISCONTINUATION NOTICE

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search

Search...